Navigation Links
Genomma Lab International Announces Second Quarter 2009 Results
Date:7/23/2009

MEXICO CITY, July 23 /PRNewswire/ -- Genomma Lab International, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), announced today its results for the quarter ended June 30, 2009. All figures included herein were prepared in accordance with Mexican GAAP; figures are stated in nominal Mexican pesos. Also, the following consolidated figures show the Company's Spanish operations reclassified as discontinued operations according to Mexican GAAP.

2Q09 Highlights (vs. 2Q08)

  • Net Sales reached Ps. 985.5 million, an increase of 50.7%.
  • Gross Profit was Ps. 724.8 million, an increase of 46.1%.
  • EBITDA(1) reached Ps. 256.9 million, an increase of 36.5%.
  • Consolidated Net Income of Ps. 122.9 million, an increase of 3.3%.
  • Earnings per Share(2) increased 16.8% to Ps. 1.03.
  • International Net Sales rose to Ps. 130.1 million, an increase of 220.9%.
  • During the second quarter, Genomma Lab successfully launched three products under three existing brands (Base Brands(3) and Prior Year Launches(4)) as part of the line extension strategy.
  • The Company also launched, during the second quarter, six products under six New Brands(5) as part of its new product launch plan.
  • As of June 30, 2009 the Company had a net cash position of Ps. 1,214.4 million.
  • During the second quarter of 2009, the Company acquired the brand of lotions Flor de Naranja Sanborns(MR), the brand of creams Teatrical, the brand of hair coloring Henna Egipcia, and a 99 year license for the use of Sanborns(MR) brands for the acquired brands.
  • Additionally, during the second quarter, the Company acquired the Jockey Club brand of men's personal care products. All of these brands are well-recognized brands in their respective markets and have been very popular among Mexican consumers for severa
    '/>"/>

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. Announces Second Quarter 2009 Results Conference Call
2. Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
3. Genomma Lab Internacional Announces First Quarter 2009 Results
4. Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
5. Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results
6. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
7. Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
8. Genomma Lab, New Participant in Market-Maker Program
9. Genomma Lab Announces Initiation of Stock Repurchase Fund
10. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
11. Genomma Lab Announces 2009 Earnings Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...November 21, 2009 Test T...est Test Test Test Test Test Test Test,Test Test T...est Test Test,Test Test Test Test Test Test Test T...test More test More test More test More test More ...test More test More test More,test More test , , ...
(Date:11/21/2009)... New Haven Dental Group merges their practice w...CT. , (PRWEB) November 21... partners Dr. David Gibson, Dr. Dean Cloutier, Dr....merged their growing practice with that of esteeme...ckman decided he wanted to retire from dentistry i...
(Date:11/20/2009)...GTON, Nov. 20 The Unite...Senate to make essential changes its health reform...rtion funding and conscience protection on abortio...d include strong provisions for adequate affordabi...are bill an "enormous disappointment" that creates...
(Date:11/20/2009)...S, Nov. 20 Centene Cor...ll present at the Bank of America Merrill Lynch 20...9, at the Crowne Plaza Hotel Times Square in New Y...cember 2nd at 8:30 a.m. Eastern Time. Investors an...o webcast of Centene,s presentation at: http://ww...
(Date:11/20/2009)...ed online November 20 in the Journal of the Natio...ars and hopes that often appear in news coverage o... for both the media and journals to help alleviate...d Steven Woloshin, M.D., M.S., of Center for Medic...ealth Policy and Clinical Practice in New Hampshir...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...egularly drink large amount of alcohol are more at...ed causes than binge drinkers, who drink a lot of ...dy had said there had more than enough attention g...ts than any other health hazards. Media had often ...
... years of age will eat as much as they are served/...ric behavior suggests that preschool children eat ...ne time. Till date it was accepted that these chil...ctors and highlights the serving portion as that g...
...by Helicobacter pylori might be responsible// for ... pylori are common bacteria that reside in the dig...ections. Previous research had connected the bacte...brillation or irregular heart beats for the Helico...
...e with abnormal heartbeats, says the new research/... 3 fatty acids that are essential to the body in t...ng and must be taken in as supplements. These fatt...gon Health & Science University School of Medicine...
...fect your memory and your learning //capabilities.... alcohol daily for even as less as eight weeks can...like learning. Researchers from St. Louis Universi...ers had tested their hypothesis on mice that after...
...ought into focus that restless leg syndrome// may ... in turn severely hamper the quality of life for t...eurological origin. This condition happens when th... or itching, or even sensations of something crawl...
Other Medicine News:
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportl...ort is available in its catalogue. ,, Global S...sing Adoption to Drive Growth ,, http://www....lood-Glucose-Market-(SMBG )-Increasing-Adoption-to...edium=pr&utm_campaign=prnewswire ,, Descr...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportl...ort is available in its catalogue. ,, Medical ... http://www.reportlinker.com/p0164242/Medical-Ad..._source=prnewswire&utm_medium=pr&utm_campa...s and sealants is gaining preeminence in medical d...
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-Firs...: BDX ) today announced the completion of its ac...n-based company that develops and manufactures mol... ,, In May 2009, BD and HandyLab announced an e...lize molecular assays on the HandyLab Jaguar(TM) p...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Arcadia HealthCares DailyMed 28TM 29 Signs Deal with Comfort Keepers 28R 29 A Leading Provider of In Home Care 53605 1Arcadia HealthCares DailyMed 28TM 29 Signs Deal with Comfort Keepers 28R 29 A Leading Provider of In Home Care 53605 2Arcadia HealthCares DailyMed 28TM 29 Signs Deal with Comfort Keepers 28R 29 A Leading Provider of In Home Care 53605 3Arcadia HealthCares DailyMed 28TM 29 Signs Deal with Comfort Keepers 28R 29 A Leading Provider of In Home Care 53605 4Arcadia HealthCares DailyMed 28TM 29 Signs Deal with Comfort Keepers 28R 29 A Leading Provider of In Home Care 53605 5VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 1Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 2Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 3Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 4Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 5Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 7Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 8Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 9Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 10Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 11Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 12Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 13Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 14Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 15Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 16Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 17Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 18Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 19Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 20Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 21Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 22Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 23
...t. 30 Emphasys Medical, Inc.,today announced that...,Zephyr(R) Endobronchial Valve (EBV) has been acce...rug Administration (FDA) and has been granted,expe...ve treatment option,intended to help patients with...pedited review based on the potential of endobronc...
...Hospital-Wide View of MRSA Infections, DUBLIN, Oh... products and services that improve the safety and...w service to help,hospitals combat methicillin-res...t are responsible for an estimated 94,000 life-thr...the U.S.(1) Cardinal Health is deploying a new MR...
Other Medicine Technology:Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve 2Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve 3Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 3
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: